Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink



Carr, D
(2019) Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink. Clinical Pharmacology and Therapeutics, 106 (6). pp. 1353-1361.

This is the latest version of this item.

[img] Text
Author_accepted_manuscript.pdf - Author Accepted Manuscript

Download (585kB) | Preview
[img] Text
Carr_et_al-2019-Clinical_Pharmacology_&_Therapeutics.pdf - Published version

Download (404kB)

Abstract

Statins can be associated with myopathy. We have undertaken a genomewide association study (GWAS ) to discover and validate genetic risk factors for statin‐induced myopathy in a “real‐world” setting. One hundred thirty‐five patients with statin myopathy recruited via the UK Clinical Practice Research Datalink were genotyped using the Illumina OmniExpress Exome version 1.0 Bead Chip and compared with the Wellcome Trust Case‐Control Consortium (n = 2,501). Nominally statistically significant single nucleotide polymorphism (SNP ) signals in the GWAS (P < 5 × 10−5) were further evaluated in several independent cohorts (comprising 332 cases and 449 drug‐tolerant controls). Only one (rs4149056/c.521C>T in the SLCO 1B1 gene) SNP was genomewide significant in the severe myopathy (creatine kinase > 10 × upper limit of normal or rhabdomyolysis) group (P = 2.55 × 10−9; odds ratio 5.15; 95% confidence interval 3.13–8.45). The association with SLCO 1B1 was present for several statins and replicated in the independent validation cohorts. The data highlight the role of SLCO 1B1 c.521C>T SNP as a replicable genetic risk factor for statin myopathy. No other novel genetic risk factors with a similar effect size were identified.

Item Type: Article
Uncontrolled Keywords: Humans, Muscular Diseases, Genetic Predisposition to Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Severity of Illness Index, Risk Factors, Case-Control Studies, Reproducibility of Results, Adverse Drug Reaction Reporting Systems, Polymorphism, Single Nucleotide, Databases, Factual, Genome-Wide Association Study, United Kingdom, Pharmacogenomic Variants, Liver-Specific Organic Anion Transporter 1
Depositing User: Symplectic Admin
Date Deposited: 31 Oct 2019 11:39
Last Modified: 19 Jan 2023 00:22
DOI: 10.1002/cpt.1557
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3058497

Available Versions of this Item